Results 41 to 50 of about 24,772 (224)

Thyrotoxic periodic paralysis

open access: yesIndian Journal of Endocrinology and Metabolism, 2011
This article aims at highlighting the importance of suspecting thyrotoxicosis in cases of recurrent periodic flaccid paralysis; especially in Asian men to facilitate early diagnosis of the former condition.
Rojith Karandode Balakrishnan   +3 more
doaj   +1 more source

Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis

open access: yesCase Reports in Endocrinology, 2020
Background. Thyroid disorders commonly affect the cardiovascular system. Thyrotoxicosis leading to pulmonary hypertension has been increasingly reported during recent years.
Narangoda Liyanage Ajantha Shyamali   +1 more
doaj   +1 more source

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

open access: yesImmunology, EarlyView.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

Use of Calcium and Alendronic Acid Preparations in Correction of Structural and Functional Disorders of Bone Tissue in Thyrotoxicosis

open access: yesBolʹ, Sustavy, Pozvonočnik, 2012
Impact of calcium and alendronic acid preparations on disorders of structural and functional state of bone tissue in experimental animals at exogenic thyrotoxicosis was studied.
O.B. Oliynyk
doaj   +1 more source

Surgical Management of Substernal Goiters: A Systematic Review and Meta‐Analysis

open access: yesThe Laryngoscope, Volume 136, Issue 2, Page 575-585, February 2026.
This systematic review and meta‐analysis of 15,706 patients with substernal goiter highlights that while surgery is often prompted by symptoms or imaging evidence of compression, over a quarter of patients were asymptomatic. The majority of cases (88.7%) were successfully managed through a cervical approach, with only a minority requiring thoracic ...
Matthew H. Cheung   +4 more
wiley   +1 more source

Prevalence of abnormal thyroid hormone levels in acute new-onset atrial fibrillation

open access: yesFrontiers in Cardiovascular Medicine
IntroductionKnown risk factors for new-onset atrial fibrillation/flutter (NOAF) include thyrotoxicosis and subclinical hypothyroidism. While prior research has predominantly explored the link between thyrotoxicosis and NOAF, the presence of subclinical ...
Jakob Hytting   +8 more
doaj   +1 more source

Comparing the Molecular Pharmacological Properties of Existing β‐Blockers to Determine the Theoretically Most “Ideal” Anti‐Cancer β‐Blocker

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT There is increasing evidence, from cellular, animal and human epidemiological studies, linking β‐blockers with reductions in cancer growth and metastasis. Propranolol is the most investigated β‐blocker for cancer; although as many different off‐patent β‐blockers exist, there is little commercial incentive to drive comparative clinical trials ...
Jillian G. Baker
wiley   +1 more source

Complete Heart Block in Thyrotoxicosis, Is It a Manifestation of Thyroid Storm? A Case Report and Review of the Literature

open access: yesCase Reports in Endocrinology, 2012
Thyrotoxicosis complicated by advance degree atrioventricular block, a rare complication of a common disease. The term apathetic thyrotoxicosis, where palpitations and cardiac involvement are the sole manifestations of disease, is well known.
Rashed Al Bannay   +2 more
doaj   +1 more source

Dementia Incidence in Patients With Prurigo Nodularis: An Observational Retrospective Cohort Study

open access: yes
JEADV Clinical Practice, EarlyView.
Madison P. Olexson   +3 more
wiley   +1 more source

Clinical Course and Risk Factors of Lenvatinib‐Related Hypothyroidism in Hepatocellular Carcinoma: A Retrospective Cohort Study

open access: yesCancer Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background Lenvatinib‐related hypothyroidism occurs in 16%–22% of patients with hepatocellular carcinoma and may affect treatment management. Previous studies have reported elevated serum thyroid stimulating hormone (TSH) levels despite levothyroxine therapy, indicating the need for research on the optimal levothyroxine dose during lenvatinib ...
Chihiro Shiraishi   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy